Latest News in the pharma Industry

All

Lhasa and Optibrium enter research and product development collaboration

Lhasa and Optibrium enter research and product development collaboration

11 Apr 2017

Drug discovery software specialists combine expertise to extend studies into drug metabolism modelling.

Read more 
Colorcon launches Colorcon Academy

Colorcon launches Colorcon Academy

10 Apr 2017

Industry leading further education programs unified and expanded.

Read more 
Phase III study shows Genentech’s Alecensa was superior to crizotinib in a specific type of lung cancer

Phase III study shows Genentech’s Alecensa was superior to crizotinib in a specific type of lung cancer

10 Apr 2017

Results showed that people treated with Alecensa lived significantly longer without their disease progressing compared to crizotinib when given as initial (first-line) treatment.

Read more 
BMS earns ENERGY STAR Partner of the Year Award for third consecutive year

BMS earns ENERGY STAR Partner of the Year Award for third consecutive year

10 Apr 2017

Company has achieved an annual energy intensity improvement of more than 3% globally, contributing to an 11.4% reduction in energy consumption since 2010.

Read more 
New technology can detect tiny ovarian tumours

New technology can detect tiny ovarian tumours

10 Apr 2017

 “Synthetic biomarkers” could be used to diagnose ovarian cancer months earlier than now possible.

Read more 
The connected factory - a reality for the process and packaging industry

The connected factory - a reality for the process and packaging industry

9 Apr 2017

Bosch showcases i4.0 solutions live at Interpack.

Read more 
Allergan reports topline Phase II data supporting advancement of Botox for the treatment of MDD

Allergan reports topline Phase II data supporting advancement of Botox for the treatment of MDD

9 Apr 2017

Botox is currently being studied as a potential treatment option for adult patients with moderate to severe MDD.

Read more 
FDA approves new indications for Harvoni and Sovaldi

FDA approves new indications for Harvoni and Sovaldi

9 Apr 2017

First HCV direct-acting antivirals approved for use in adolescents.

Read more 
Merck receives CRL from the FDA for TECOS study with sitagliptin

Merck receives CRL from the FDA for TECOS study with sitagliptin

7 Apr 2017

CRL relates to Merck's sNDA for Januvia, Janumet and Janumet XR.

Read more 
Hikma enters into settlement agreement with Jazz for sodium oxybate

Hikma enters into settlement agreement with Jazz for sodium oxybate

6 Apr 2017

Agreement terms are "favourable for both parties".

Read more 
Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications

Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications

6 Apr 2017

ECF843 is a new therapeutic approach and potential first-in-class Rx treatment in dry-eye.

Read more 
RedHill Biopharma signs exclusive US license from Entera health for commercial GI product EnteraGam

RedHill Biopharma signs exclusive US license from Entera health for commercial GI product EnteraGam

6 Apr 2017

RedHill expects to initiate US promotion of its two commercially-available gastrointestinal specialty products, Donnatal and EnteraGam, in mid-2017.

Read more